News

Govt exempts new patented drugs from price control order for 5 yrs

drugs

The Government has exempted new drugs patented under the Indian Patent Act from the price control order for five years from the date of their marketing, according to a notification.

dIgitalhealth

drugsThe Drugs (Prices Control) Amendment Order, 2019, by the Ministry of Chemicals and Fertilisers exempts “a manufacturer producing a new drug patented under the Indian Patent Act, 1970 (39 of 1970), for a period of five years from the date of commencement of its commcercial marketing by the manufacturer in the country,” the notification as quoted by a prominent news agency said.

The provisions of DPCO 2013 shall not apply to “drugs for treating orphan diseases as decided by the Ministry of Health and Family Welfare”, it said.

The Drug Price Control Orders (DPCO) fixes the prices of scheduled formulations and monitors maximum retail prices of all drugs, including the non-scheduled formulations.

dIgitalhealth

The notification also mentioned that “the source of market-based data shall be the data available with the pharmaceutical market data specialising company as decided by the government, and if the government deems it necessary, it may validate such data by appropriate survey or evaluation.

The notification said for “fixing or revising the ceiling price for formulations, the government may, if it is necessary so to do, consider market based data available for any month, as deemed fit.

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on


Most Popular

SUBSCRIBE OUR NEWSLETTER
200000+ Subscribers read it every day.
Subscribe Newsletter
To Top